European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolismChristian Pristipino, Giuseppe Biondi‐Zoccai, Horst Sievert et al.|European Heart Journal|2018Cited by 435
Mortality in patients treated with extended duration dual antiplatelet therapy after drug-eluting stent implantation: a pairwise and Bayesian network meta-analysis of randomised trialsTullio Palmerini, Gregg W. Stone, Umberto Benedetto et al.|The Lancet|2015Cited by 394
Three, six, or twelve months of dual antiplatelet therapy after DES implantation in patients with or without acute coronary syndromes: an individual patient data pairwise and network meta-analysis of six randomized trials and 11 473 patientsTullio Palmerini, Gregg W. Stone, Martine Gilard et al.|European Heart Journal|2016Cited by 200
Short- Versus Long-Term Dual Antiplatelet Therapy After Drug-Eluting Stent ImplantationTullio Palmerini, Gregg W. Stone, Diego Sangiorgi et al.|Journal of the American College of Cardiology|2015Cited by 168
Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trialsMattía Galli, Dominick J. Angiolillo, Stefano Benenati et al.|European Heart Journal|2021Cited by 150